Herbal research: The good, the bad and the worrying

Complementary Therapies in Medicine

Volumn 15, Issue 1, 2007, Pages 1-2

  Mills, Simon Y ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; NEW DRUG; SABAL EXTRACT;

AESCULUS HIPPOCASTANUM; ALTERNATIVE MEDICINE; CIMICIFUGA RACEMOSA; DRUG EFFICACY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; GINKGO BILOBA; GOOD MANUFACTURING PRACTICE; GOVERNMENT REGULATION; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; LICENCE; NONHUMAN; PATENT; PHYTOTHERAPY; PIPER METHYSTICUM; REGISTRATION; RESEARCH ETHICS; SABAL;

BIOMEDICAL RESEARCH; COMMERCE; EUROPE; HUMANS; INVESTMENTS; LEGISLATION, DRUG; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 33847621241     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2007.01.003     Document Type: Editorial

References (5)

1. European Scientific Cooperative on Phytotherapy. ESCOP monographs: the scientific foundation for herbal medicinal products (2003), Georg Thieme Verlag, Exeter: ESCOP and Stuttgart
2. Wolsko P.M., Solondz D.K., Phillips R.S., Schachter S.C., and Eisenberg D.M. Lack of herbal supplement characterization in published randomized controlled trials. Am J Med 118 10 (2005) 1087-1093
3. Kressman S., Muller W.E., and Blume H.H. Pharmaceutical quality of different Ginkgo biloba brands. J Pharm Pharmacol 54 5 (2002) 661-669
4. Directive 2004/24/EC of the European Parliament and of the Council. Off J Eur Union L136/86 April (30) (2004) 3 [Article 16 (a)]
5. Blumenthal M., and Cavaliere C. NCCAM funds new African and Chinese herbal research programs. Herbalgram 71 (2006) 20-22